<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35868344</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8409</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Expert review of clinical immunology</Title><ISOAbbreviation>Expert Rev Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics.</ArticleTitle><Pagination><StartPage>947</StartPage><EndPage>960</EndPage><MedlinePgn>947-960</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/1744666X.2022.2105697</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Infection with COVID-19 results in acute respiratory symptoms followed by long COVID multi-organ effects presenting with neurological, cardiovascular, musculoskeletal, and gastrointestinal (GI) manifestations. Temporal relationship between gastrointestinal and neurological symptoms is unclear but warranted for exploring better clinical care for COVID-19 patients.</AbstractText><AbstractText Label="AREAS COVERED">We critically reviewed the temporal relationship between gut-brain axis after SARS-CoV-2 infection and the molecular mechanisms involved in neuroinvasion following GI infection. Mediators are identified that could serve as biomarkers and therapeutic targets in SARS-CoV-2. We discussed the potential therapeutic approaches to mitigate the effects of GI infection with SARS-CoV-2.</AbstractText><AbstractText Label="EXPERT OPINION">Altered gut microbiota cause increased expression of various mediators, including zonulin causing disruption of tight junction. This stimulates enteric nervous system and signals to CNS precipitating neurological sequalae. Published reports suggest potential role of cytokines, immune cells, B(0)AT1 (SLC6A19), ACE2, TMRSS2, TMPRSS4, IFN-&#x3b3;, IL-17A, zonulin, and altered gut microbiome in gut-brain axis and associated neurological sequalae. Targeting these mediators and gut microbiome to improve immunity will be of therapeutic significance. In-depth research and well-designed large-scale population-based clinical trials with multidisciplinary and collaborative approaches are warranted. Investigating the temporal relationship between organs involved in long-term sequalae is critical due to evolving variants of SARS-CoV-2.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wais</LastName><ForeName>Tameena</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Translational Research, College of Osteopathic Medicine of the Pacific. Western University of Health Sciences, Pomona, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasan</LastName><ForeName>Mehde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Translational Research, College of Osteopathic Medicine of the Pacific. Western University of Health Sciences, Pomona, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rai</LastName><ForeName>Vikrant</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-6286-2341</Identifier><AffiliationInfo><Affiliation>Department of Translational Research, College of Osteopathic Medicine of the Pacific. Western University of Health Sciences, Pomona, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Devendra K</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0001-5445-0013</Identifier><AffiliationInfo><Affiliation>Department of Translational Research, College of Osteopathic Medicine of the Pacific. Western University of Health Sciences, Pomona, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL144125</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL147662</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Clin Immunol</MedlineTA><NlmUniqueID>101271248</NlmUniqueID><ISSNLinking>1744-666X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087502" MajorTopicYN="Y">Brain-Gut Axis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE-2 receptor</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Gut-brain axis</Keyword><Keyword MajorTopicYN="N">enteric nervous system</Keyword><Keyword MajorTopicYN="N">gastrointestinal tract</Keyword></KeywordList><CoiStatement>Declaration of interest. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35868344</ArticleId><ArticleId IdType="mid">NIHMS1830084</ArticleId><ArticleId IdType="pmc">PMC9388545</ArticleId><ArticleId IdType="doi">10.1080/1744666X.2022.2105697</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg. 2020;61(3):E304&#x2013;E12. Epub 2020/11/06. doi: 10.15167/2421-4248/jpmh2020.61.3.1530.</Citation><ArticleIdList><ArticleId IdType="doi">10.15167/2421-4248/jpmh2020.61.3.1530</ArticleId><ArticleId IdType="pmc">PMC7595075</ArticleId><ArticleId IdType="pubmed">33150219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nooti SK, Rai V, Singh H, Potluri V, Agrawal DK. Strokes, Neurological, and Neuropsychiatric Disorders in COVID-19. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications: Springer; 2021. p. 209&#x2013;31.</Citation></Reference><Reference><Citation>Dixon BE, Wools-Kaloustian K, Fadel WF, Duszynski TJ, Yiannoutsos C, Halverson PK, et al. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study. medRxiv. 2020. Epub 2020/10/28. doi: 10.1101/2020.10.11.20210922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.11.20210922</ArticleId><ArticleId IdType="pmc">PMC7990210</ArticleId><ArticleId IdType="pubmed">33760821</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;90. Epub 2020/04/11. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279&#x2013;84. Epub 2020/07/04. doi: 10.1136/svn-2020-000431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000431</ArticleId><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDougall M, El-Hajj Sleiman J, Beauchemin P, Rangachari M. SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Front Immunol. 2022;13:871276. Epub 2022/05/17. doi: 10.3389/fimmu.2022.871276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.871276</ArticleId><ArticleId IdType="pmc">PMC9102605</ArticleId><ArticleId IdType="pubmed">35572514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellucci G, Rinaldi V, Buscarinu MC, Renie R, Bigi R, Pellicciari G, et al. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? Front Immunol. 2021;12:755333. Epub 2021/10/15. doi: 10.3389/fimmu.2021.755333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.755333</ArticleId><ArticleId IdType="pmc">PMC8503550</ArticleId><ArticleId IdType="pubmed">34646278</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelena G, Casas M, Eizaguirre MB, Pita MC, Cohen L, Alonso R, et al. inverted question mark Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis. Mult Scler Relat Disord. 2022;57:103368. Epub 2022/02/16. doi: 10.1016/j.msard.2021.103368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103368</ArticleId><ArticleId IdType="pubmed">35158474</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020;194:105921. Epub 2020/05/19. doi: 10.1016/j.clineuro.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Andalib S, Biller J, Di Napoli M, Moghimi N, McCullough LD, Rubinos CA, et al. Peripheral Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21(3):9. Epub 2021/02/16. doi: 10.1007/s11910-021-01102-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01102-5</ArticleId><ArticleId IdType="pmc">PMC7882462</ArticleId><ArticleId IdType="pubmed">33586020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Jiang X, Zhang Z, Huang S, Zhang Z, Fang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69(6):997&#x2013;1001. Epub 2020/04/04. doi: 10.1136/gutjnl-2020-321013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321013</ArticleId><ArticleId IdType="pubmed">32241899</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorens S, Nava E, Munoz-Lopez M, Sanchez-Larsen A, Segura T. Neurological Symptoms of COVID-19: The Zonulin Hypothesis. Front Immunol. 2021;12:665300. Epub 2021/05/14. doi: 10.3389/fimmu.2021.665300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.665300</ArticleId><ArticleId IdType="pmc">PMC8107207</ArticleId><ArticleId IdType="pubmed">33981312</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanopoulos M, Gkeros F, Doukatas A, Karianakis G, Pontas C, Tsoukalas N, et al. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020;26(31):4579&#x2013;88. Epub 2020/09/05. doi: 10.3748/wjg.v26.i31.4579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v26.i31.4579</ArticleId><ArticleId IdType="pmc">PMC7445869</ArticleId><ArticleId IdType="pubmed">32884218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahim Nakhli R, Shanker A, Sarosiek I, Boschman J, Espino K, Sigaroodi S, et al. Gastrointestinal symptoms and the severity of COVID-19: Disorders of gut-brain interaction are an outcome. Neurogastroenterol Motil. 2022:e14368. Epub 2022/04/07. doi: 10.1111/nmo.14368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14368</ArticleId><ArticleId IdType="pmc">PMC9115309</ArticleId><ArticleId IdType="pubmed">35383423</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022;434:120162. Epub 2022/02/06. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential Long Coronavirus Disease 2019 Gastrointestinal Symptoms 6 Months After Coronavirus Infection Are Associated With Mental Health Symptoms. Gastroenterology. 2022;162(2):648&#x2013;50 e2. Epub 2021/11/04. doi: 10.1053/j.gastro.2021.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.040</ArticleId><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707. Epub 2022/03/08. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni TE, Medici V, Moretti M, Visona SD, Cirrincione A, Carlos AF, et al. COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol. 2021;31(5):e12997. Epub 2021/06/20. doi: 10.1111/bpa.12997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12997</ArticleId><ArticleId IdType="pmc">PMC8412067</ArticleId><ArticleId IdType="pubmed">34145669</ArticleId></ArticleIdList></Reference><Reference><Citation>Generoso JS, Barichello de Quevedo JL, Cattani M, Lodetti BF, Sousa L, Collodel A, et al. Neurobiology of COVID-19: how can the virus affect the brain? Braz J Psychiatry. 2021;43(6):650&#x2013;64. Epub 2021/02/20. doi: 10.1590/1516-4446-2020-1488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-4446-2020-1488</ArticleId><ArticleId IdType="pmc">PMC8639021</ArticleId><ArticleId IdType="pubmed">33605367</ArticleId></ArticleIdList></Reference><Reference><Citation>Radnis C, Qiu S, Jhaveri M, Da Silva I, Szewka A, Koffman L. Radiographic and clinical neurologic manifestations of COVID-19 related hypoxemia. J Neurol Sci. 2020;418:117119. Epub 2020/09/22. doi: 10.1016/j.jns.2020.117119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117119</ArticleId><ArticleId IdType="pmc">PMC7474836</ArticleId><ArticleId IdType="pubmed">32957036</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203&#x2013;9. Epub 2015/04/02.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4367209</ArticleId><ArticleId IdType="pubmed">25830558</ArticleId></ArticleIdList></Reference><Reference><Citation>Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8):e1002533. Epub 2016/08/20. doi: 10.1371/journal.pbio.1002533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002533</ArticleId><ArticleId IdType="pmc">PMC4991899</ArticleId><ArticleId IdType="pubmed">27541692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12(8):453&#x2013;66. Epub 2011/07/14. doi: 10.1038/nrn3071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3071</ArticleId><ArticleId IdType="pmc">PMC3845678</ArticleId><ArticleId IdType="pubmed">21750565</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113(2):411&#x2013;7. Epub 2012/05/23. doi: 10.1111/j.1365-2672.2012.05344.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2672.2012.05344.x</ArticleId><ArticleId IdType="pubmed">22612585</ArticleId></ArticleIdList></Reference><Reference><Citation>Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69(8):1543&#x2013;4. Epub 2020/04/22. doi: 10.1136/gutjnl-2020-321388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321388</ArticleId><ArticleId IdType="pmc">PMC7211078</ArticleId><ArticleId IdType="pubmed">32312790</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493. Epub 2020/11/01. doi: 10.1038/s41467-020-19057-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19057-5</ArticleId><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538&#x2013;41. Epub 2011/10/28. doi: 10.1038/nature10554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10554</ArticleId><ArticleId IdType="pubmed">22031325</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohle L, Mattei D, Heimesaat MM, Bereswill S, Fischer A, Alutis M, et al. Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis. Cell Rep. 2016;15(9):1945&#x2013;56. Epub 2016/05/24. doi: 10.1016/j.celrep.2016.04.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.04.074</ArticleId><ArticleId IdType="pubmed">27210745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485&#x2013;98. Epub 2009/10/20. doi: 10.1016/j.cell.2009.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.09.033</ArticleId><ArticleId IdType="pmc">PMC2796826</ArticleId><ArticleId IdType="pubmed">19836068</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31(4):677&#x2013;89. Epub 2009/10/17. doi: 10.1016/j.immuni.2009.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.08.020</ArticleId><ArticleId IdType="pubmed">19833089</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965&#x2013;77. Epub 2015/06/02. doi: 10.1038/nn.4030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4030</ArticleId><ArticleId IdType="pmc">PMC5528863</ArticleId><ArticleId IdType="pubmed">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5(14). Epub 2020/06/20. doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P. Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis. Trends Neurosci. 2019;42(1):4&#x2013;13. Epub 2018/10/22. doi: 10.1016/j.tins.2018.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.09.007</ArticleId><ArticleId IdType="pmc">PMC6623978</ArticleId><ArticleId IdType="pubmed">30342839</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12:698169. Epub 2021/07/13. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther. 2015;37(5):984&#x2013;95. Epub 2015/06/06. doi: 10.1016/j.clinthera.2015.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2015.04.002</ArticleId><ArticleId IdType="pmc">PMC4458706</ArticleId><ArticleId IdType="pubmed">26046241</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajdel-Sulkowska EM. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling. Biomed Res Int. 2021;2021:7880448. Epub 2021/10/16. doi: 10.1155/2021/7880448. Interest.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7880448</ArticleId><ArticleId IdType="pmc">PMC8510788</ArticleId><ArticleId IdType="pubmed">34651049</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health. 2021;14:100251. Epub 2021/04/13. doi: 10.1016/j.bbih.2021.100251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100251</ArticleId><ArticleId IdType="pmc">PMC8019247</ArticleId><ArticleId IdType="pubmed">33842898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, et al. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother. 2021;133:111064. Epub 2021/01/01. doi: 10.1016/j.biopha.2020.111064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.111064</ArticleId><ArticleId IdType="pmc">PMC7700011</ArticleId><ArticleId IdType="pubmed">33378966</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraco G, Brea D, Garcia-Bonilla L, Wang G, Racchumi G, Chang H, et al. Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response. Nat Neurosci. 2018;21(2):240&#x2013;9. Epub 2018/01/18. doi: 10.1038/s41593-017-0059-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0059-z</ArticleId><ArticleId IdType="pmc">PMC6207376</ArticleId><ArticleId IdType="pubmed">29335605</ArticleId></ArticleIdList></Reference><Reference><Citation>Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med. 2016;22(5):516&#x2013;23. Epub 2016/03/29. doi: 10.1038/nm.4068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4068</ArticleId><ArticleId IdType="pmc">PMC4860105</ArticleId><ArticleId IdType="pubmed">27019327</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337&#x2013;41. Epub 2015/06/02. doi: 10.1038/nature14432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14432</ArticleId><ArticleId IdType="pmc">PMC4506234</ArticleId><ArticleId IdType="pubmed">26030524</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Wu Z, Zhang M, Liu S, Zhou L, Yang C, et al. The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2. Front Neurosci. 2021;15:694446. Epub 2021/07/20. doi: 10.3389/fnins.2021.694446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.694446</ArticleId><ArticleId IdType="pmc">PMC8283125</ArticleId><ArticleId IdType="pubmed">34276298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinu P, Morsy MA, Deb PK, Nair AB, Goyal M, Shah J, et al. SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness. Front Mol Biosci. 2020;7:606779. Epub 2021/01/09. doi: 10.3389/fmolb.2020.606779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.606779</ArticleId><ArticleId IdType="pmc">PMC7783391</ArticleId><ArticleId IdType="pubmed">33415126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan D, Du T, Hong W, Chen L, Que H, Lu S, et al. Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther. 2021;6(1):406. Epub 2021/11/25. doi: 10.1038/s41392-021-00818-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00818-7</ArticleId><ArticleId IdType="pmc">PMC8609271</ArticleId><ArticleId IdType="pubmed">34815399</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach TG, Corbille AG, Letournel F, Kordower JH, Kremer T, Munoz DG, et al. Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects. J Parkinsons Dis. 2016;6(4):761&#x2013;70. Epub 2016/10/22. doi: 10.3233/JPD-160888.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-160888</ArticleId><ArticleId IdType="pmc">PMC5501392</ArticleId><ArticleId IdType="pubmed">27589538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaumette T, Lebouvier T, Aubert P, Lardeux B, Qin C, Li Q, et al. Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism. Neurogastroenterol Motil. 2009;21(2):215&#x2013;22. Epub 2008/12/17. doi: 10.1111/j.1365-2982.2008.01226.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2008.01226.x</ArticleId><ArticleId IdType="pubmed">19077145</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li Y, Liu C, Fan R, Wang P, Zheng L, et al. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats. Transl Res. 2015;166(2):152&#x2013;62. Epub 2015/03/15. doi: 10.1016/j.trsl.2015.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2015.02.003</ArticleId><ArticleId IdType="pubmed">25766133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862. Epub 2020/10/25. doi: 10.1136/bmj.m3862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3862</ArticleId><ArticleId IdType="pubmed">33097561</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med J. 2021;97(1147):312&#x2013;20. Epub 2020/09/27. doi: 10.1136/postgradmedj-2020-138577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138577</ArticleId><ArticleId IdType="pmc">PMC10017004</ArticleId><ArticleId IdType="pubmed">32978337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Faiq MA, Pareek V, Raza K, Narayan RK, Prasoon P, et al. Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients. Med Hypotheses. 2020;144:110271. Epub 2020/12/02. doi: 10.1016/j.mehy.2020.110271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110271</ArticleId><ArticleId IdType="pmc">PMC7487155</ArticleId><ArticleId IdType="pubmed">33254575</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DJ, Lockwood J, Das P, Wang R, Grinspun E, Lee JM. Self-reported anosmia and dysgeusia as key symptoms of coronavirus disease 2019. CJEM. 2020;22(5):595&#x2013;602. Epub 2020/06/09. doi: 10.1017/cem.2020.420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cem.2020.420</ArticleId><ArticleId IdType="pmc">PMC7308595</ArticleId><ArticleId IdType="pubmed">32507123</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264&#x2013;75. Epub 2008/05/23. doi: 10.1128/JVI.00737-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito G, Capoccia E, Gigli S, Pesce M, Bruzzese E, D'Alessandro A, et al. HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system. Sci Rep. 2017;7(1):7735. Epub 2017/08/12. doi: 10.1038/s41598-017-05245-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05245-9</ArticleId><ArticleId IdType="pmc">PMC5552820</ArticleId><ArticleId IdType="pubmed">28798420</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda K, Park CH, Sunden Y, Kimura T, Ochiai K, Kida H, et al. The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice. Vet Pathol. 2004;41(2):101&#x2013;7. Epub 2004/03/16. doi: 10.1354/vp.41-2-101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1354/vp.41-2-101</ArticleId><ArticleId IdType="pubmed">15017022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dube M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43. J Virol. 2018;92(17). Epub 2018/06/22. doi: 10.1128/JVI.00404-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00404-18</ArticleId><ArticleId IdType="pmc">PMC6096804</ArticleId><ArticleId IdType="pubmed">29925652</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole-Jeffrey CT, Liu M, Katovich MJ, Raizada MK, Shenoy V. ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy. J Cardiovasc Pharmacol. 2015;66(6):540&#x2013;50. Epub 2015/09/01. doi: 10.1097/FJC.0000000000000307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000307</ArticleId><ArticleId IdType="pmc">PMC4807023</ArticleId><ArticleId IdType="pubmed">26322922</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisoli E, Cinti S, Valerio A. COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption. Eat Weight Disord. 2021;26(5):1647&#x2013;51. Epub 2020/07/22. doi: 10.1007/s40519-020-00963-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40519-020-00963-y</ArticleId><ArticleId IdType="pmc">PMC7369504</ArticleId><ArticleId IdType="pubmed">32691334</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477&#x2013;81. Epub 2012/07/28. doi: 10.1038/nature11228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11228</ArticleId><ArticleId IdType="pmc">PMC7095315</ArticleId><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Belladonna ML, Orabona C. Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19. Front Pharmacol. 2020;11:959. Epub 2020/07/09. doi: 10.3389/fphar.2020.00959.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00959</ArticleId><ArticleId IdType="pmc">PMC7319082</ArticleId><ArticleId IdType="pubmed">32636755</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux CA, Lagier JC, Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne). 2021;8:640073. Epub 2021/03/09. doi: 10.3389/fmed.2021.640073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.640073</ArticleId><ArticleId IdType="pmc">PMC7930624</ArticleId><ArticleId IdType="pubmed">33681266</ArticleId></ArticleIdList></Reference><Reference><Citation>George AK, Behera J, Homme RP, Tyagi N, Tyagi SC, Singh M. Rebuilding Microbiome for Mitigating Traumatic Brain Injury: Importance of Restructuring the Gut-Microbiome-Brain Axis. Mol Neurobiol. 2021;58(8):3614&#x2013;27. Epub 2021/03/29. doi: 10.1007/s12035-021-02357-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02357-2</ArticleId><ArticleId IdType="pmc">PMC8003896</ArticleId><ArticleId IdType="pubmed">33774742</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothhammer V, Borucki DM, Tjon EC, Takenaka MC, Chao CC, Ardura-Fabregat A, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557(7707):724&#x2013;8. Epub 2018/05/18. doi: 10.1038/s41586-018-0119-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0119-x</ArticleId><ArticleId IdType="pmc">PMC6422159</ArticleId><ArticleId IdType="pubmed">29769726</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson G, Reiter RJ. Melatonin: Roles in influenza, Covid-19, and other viral infections. Rev Med Virol. 2020;30(3):e2109. Epub 2020/04/22. doi: 10.1002/rmv.2109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2109</ArticleId><ArticleId IdType="pmc">PMC7235470</ArticleId><ArticleId IdType="pubmed">32314850</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter RJ, Sharma R, Simko F, Dominguez-Rodriguez A, Tesarik J, Neel RL, et al. Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection. Cell Mol Life Sci. 2022;79(3):143. Epub 2022/02/22. doi: 10.1007/s00018-021-04102-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-04102-3</ArticleId><ArticleId IdType="pmc">PMC8858600</ArticleId><ArticleId IdType="pubmed">35187603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan SH, Lee HZ, Chao CM, Chang SP, Lu LC, Lai CC. Efficacy of melatonin in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. J Med Virol. 2022;94(5):2102&#x2013;7. Epub 2022/01/16. doi: 10.1002/jmv.27595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27595</ArticleId><ArticleId IdType="pmc">PMC9015545</ArticleId><ArticleId IdType="pubmed">35032042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma L, Riva A. Intestinal Barrier Function in Health and Disease-Any role of SARS-CoV-2? Microorganisms. 2020;8(11). Epub 2020/11/12. doi: 10.3390/microorganisms8111744.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8111744</ArticleId><ArticleId IdType="pmc">PMC7694956</ArticleId><ArticleId IdType="pubmed">33172188</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva A, Cammisotto V, Cangemi R, Ferro D, Miele MC, De Angelis M, et al. Low-Grade Endotoxemia and Thrombosis in COVID-19. Clin Transl Gastroenterol. 2021;12(6):e00348. Epub 2021/06/08. doi: 10.14309/ctg.0000000000000348.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000348</ArticleId><ArticleId IdType="pmc">PMC8183715</ArticleId><ArticleId IdType="pubmed">34092777</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Liu T, Yang N, Han D, Mi X, Li Y, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020;14(5):533&#x2013;41. Epub 2020/05/06. doi: 10.1007/s11684-020-0786-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0786-5</ArticleId><ArticleId IdType="pmc">PMC7197033</ArticleId><ArticleId IdType="pubmed">32367431</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168&#x2013;75. Epub 2020/12/02. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojetti V, Saviano A, Covino M, Acampora N, Troiani E, Franceschi F, et al. COVID-19 and intestinal inflammation: Role of fecal calprotectin. Dig Liver Dis. 2020;52(11):1231&#x2013;3. Epub 2020/10/17. doi: 10.1016/j.dld.2020.09.015. grant support</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.09.015</ArticleId><ArticleId IdType="pmc">PMC7508507</ArticleId><ArticleId IdType="pubmed">33060042</ArticleId></ArticleIdList></Reference><Reference><Citation>Skarlis C, Nezos A, Mavragani CP, Koutsilieris M. The role of insulin growth factors in autoimmune diseases. Ann Res Hosp. 2019;3(10).</Citation></Reference><Reference><Citation>Li G, Zhou L, Zhang C, Shi Y, Dong D, Bai M, et al. Insulin-Like Growth Factor 1 Regulates Acute Inflammatory Lung Injury Mediated by Influenza Virus Infection. Front Microbiol. 2019;10:2541. Epub 2019/12/19. doi: 10.3389/fmicb.2019.02541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.02541</ArticleId><ArticleId IdType="pmc">PMC6887893</ArticleId><ArticleId IdType="pubmed">31849847</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Yin C, Wang J, Yang M, Ma H, Jin G, et al. Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank. Eur J Epidemiol. 2021;36(3):311&#x2013;8. Epub 2021/01/10. doi: 10.1007/s10654-020-00709-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00709-1</ArticleId><ArticleId IdType="pmc">PMC7794621</ArticleId><ArticleId IdType="pubmed">33420872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BH, Ahn JH, Park JH, Song M, Kim H, Lee TK, et al. Rufinamide, an antiepileptic drug, improves cognition and increases neurogenesis in the aged gerbil hippocampal dentate gyrus via increasing expressions of IGF-1, IGF-1R and p-CREB. Chem Biol Interact. 2018;286:71&#x2013;7. Epub 2018/03/20. doi: 10.1016/j.cbi.2018.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2018.03.007</ArticleId><ArticleId IdType="pubmed">29548728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge RT, Mo LH, Wu R, Liu JQ, Zhang HP, Liu Z, et al. Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine. Sci Rep. 2015;5:7735. Epub 2015/01/16. doi: 10.1038/srep07735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep07735</ArticleId><ArticleId IdType="pmc">PMC4295102</ArticleId><ArticleId IdType="pubmed">25588622</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. Epub 2020/01/28. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PH, Tay WC, Sutjipto S, Fong SW, Ong SWX, Wei WE, et al. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Clin Transl Immunology. 2020;9(7):e1160. Epub 2020/08/04. doi: 10.1002/cti2.1160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1160</ArticleId><ArticleId IdType="pmc">PMC7385430</ArticleId><ArticleId IdType="pubmed">32742654</ArticleId></ArticleIdList></Reference><Reference><Citation>A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19). Available from http://www.chictr.org.cn/showprojen.aspx?proj=50251.</Citation></Reference><Reference><Citation>Rossi AD, de Araujo JLF, de Almeida TB, Ribeiro-Alves M, de Almeida Velozo C, Almeida JM, et al. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress. Sci Rep. 2021;11(1):9658. Epub 2021/05/08. doi: 10.1038/s41598-021-88944-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88944-8</ArticleId><ArticleId IdType="pmc">PMC8102547</ArticleId><ArticleId IdType="pubmed">33958627</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Castrellon P, Gandara-Marti T, Abreu YAAT, Nieto-Rufino CD, Lopez-Orduna E, Jimenez-Escobar I, et al. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. 2022;14(1):2018899. Epub 2022/01/12. doi: 10.1080/19490976.2021.2018899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.2018899</ArticleId><ArticleId IdType="pmc">PMC8757475</ArticleId><ArticleId IdType="pubmed">35014600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159(3):944&#x2013;55 e8. Epub 2020/05/23. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes. 2020;11(2):135&#x2013;57. Epub 2019/08/02. doi: 10.1080/19490976.2019.1638722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2019.1638722</ArticleId><ArticleId IdType="pmc">PMC7053956</ArticleId><ArticleId IdType="pubmed">31368397</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701&#x2013;12. Epub 2012/09/13. doi: 10.1038/nrn3346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3346</ArticleId><ArticleId IdType="pubmed">22968153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadlallah S, Sham Eddin MS, Rahal EA. IL-17A in COVID-19 Cases: a meta-analysis. J Infect Dev Ctries. 2021;15(11):1630&#x2013;9. Epub 2021/12/14. doi: 10.3855/jidc.15285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.15285</ArticleId><ArticleId IdType="pubmed">34898490</ArticleId></ArticleIdList></Reference><Reference><Citation>Carugno A, Gambini DM, Raponi F, Vezzoli P, Locatelli AGC, Di Mercurio M, et al. COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy. J Am Acad Dermatol. 2020;83(1):292&#x2013;4. Epub 2020/05/11. doi: 10.1016/j.jaad.2020.04.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.04.165</ArticleId><ArticleId IdType="pmc">PMC7202829</ArticleId><ArticleId IdType="pubmed">32387660</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger JG, Murrell DF, Garcet S, Navrazhina K, Lee PC, Muscianisi E, et al. Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis. J Allergy Clin Immunol. 2021;147(3):1107&#x2013;9 e2. Epub 2020/10/02. doi: 10.1016/j.jaci.2020.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.09.021</ArticleId><ArticleId IdType="pmc">PMC7834246</ArticleId><ArticleId IdType="pubmed">33002515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragia G, Manolopoulos VG. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies. Eur J Clin Pharmacol. 2020;76(12):1623&#x2013;30. Epub 2020/07/23. doi: 10.1007/s00228-020-02963-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-020-02963-4</ArticleId><ArticleId IdType="pmc">PMC7372205</ArticleId><ArticleId IdType="pubmed">32696234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Hofmann-Winkler H, Smith JC, Kruger N, Arora P, Sorensen LK, et al. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine. 2021;65:103255. Epub 2021/03/08. doi: 10.1016/j.ebiom.2021.103255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103255</ArticleId><ArticleId IdType="pmc">PMC7930809</ArticleId><ArticleId IdType="pubmed">33676899</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Meyerholz DK, Bartlett JA, McCray PB Jr. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. mBio. 2021;12(4):e0097021. Epub 2021/08/04. doi: 10.1128/mBio.00970-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00970-21</ArticleId><ArticleId IdType="pmc">PMC8406266</ArticleId><ArticleId IdType="pubmed">34340553</ArticleId></ArticleIdList></Reference><Reference><Citation>National Library of Medicine (U.S.). (2020, April-). The Impact of Camostat Mesilate on COVID-19 Infection (CamoCO-19). Identifier NCT04321096. https://clinicaltrials.gov/ct2/show/NCT04321096.</Citation></Reference><Reference><Citation>National Library of Medicine (U.S.). (2021, June-). Efficacy of Nafamostat in Covid-19 Patients (RACONA Study) (RACONA). Identifier NCT04352400. https://clinicaltrials.gov/ct2/show/NCT04352400</Citation></Reference><Reference><Citation>Ungerstedt JS, Blomback M, Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol. 2003;131(1):48&#x2013;52. Epub 2003/01/10. doi: 10.1046/j.1365-2249.2003.02031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2003.02031.x</ArticleId><ArticleId IdType="pmc">PMC1808598</ArticleId><ArticleId IdType="pubmed">12519385</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay O, Arif M, Li X, Yang H, Aydin M, Alkurt G, et al. Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19. Adv Sci (Weinh). 2021;8(17):e2101222. Epub 2021/06/29. doi: 10.1002/advs.202101222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202101222</ArticleId><ArticleId IdType="pmc">PMC8420376</ArticleId><ArticleId IdType="pubmed">34180141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermel M, Sweeney M, Ni YM, Bonakdar R, Triffon D, Suhar C, et al. Natural Supplements for COVID19-Background, Rationale, and Clinical Trials. J Evid Based Integr Med. 2021;26:2515690X211036875. Epub 2021/08/14. doi: 10.1177/2515690X211036875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2515690X211036875</ArticleId><ArticleId IdType="pmc">PMC8369961</ArticleId><ArticleId IdType="pubmed">34384258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanimoto K, Hirota K, Fukazawa T, Matsuo Y, Nomura T, Tanuza N, et al. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal. Sci Rep. 2021;11(1):16629. Epub 2021/08/19. doi: 10.1038/s41598-021-96109-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96109-w</ArticleId><ArticleId IdType="pmc">PMC8371152</ArticleId><ArticleId IdType="pubmed">34404832</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, et al. Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation. Int J Mol Sci. 2021;22(17). Epub 2021/09/11. doi: 10.3390/ijms22179427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179427</ArticleId><ArticleId IdType="pmc">PMC8431481</ArticleId><ArticleId IdType="pubmed">34502335</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Micco S, Musella S, Scala MC, Sala M, Campiglia P, Bifulco G, et al. In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate. Front Chem. 2020;8:628609. Epub 2021/02/02. doi: 10.3389/fchem.2020.628609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2020.628609</ArticleId><ArticleId IdType="pmc">PMC7843458</ArticleId><ArticleId IdType="pubmed">33520943</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Gilboa T, Ogata AF, Senussi Y, Lazarovits R, Boribong BP, et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021;131(14). Epub 2021/05/26. doi: 10.1172/JCI149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021;384(9):795&#x2013;807. Epub 2020/12/12. doi: 10.1056/NEJMoa2031994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2031994</ArticleId><ArticleId IdType="pmc">PMC7745180</ArticleId><ArticleId IdType="pubmed">33306283</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis G, Li K, Thankam FG, Wilson DR, Agrawal DK. Ocular transmissibility of COVID-19: possibilities and perspectives. Mol Cell Biochem. 2022;477(3):849&#x2013;64. Epub 2022/01/24. doi: 10.1007/s11010-021-04336-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04336-6</ArticleId><ArticleId IdType="pmc">PMC8783769</ArticleId><ArticleId IdType="pubmed">35066705</ArticleId></ArticleIdList></Reference><Reference><Citation>Thankam FG, Agrawal DK. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases. J Thorac Cardiovasc Surg. 2021;161(2):e217&#x2013;e26. Epub 2020/07/08. doi: 10.1016/j.jtcvs.2020.05.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.05.083</ArticleId><ArticleId IdType="pmc">PMC7834736</ArticleId><ArticleId IdType="pubmed">32631657</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>